Pennsylvania-based Representative Chaka Fattah -- a U.S. Congressman behind the Fattah Neuroscience Initiative, which aims to drive collaborative Federal research on brain cognition, development, disease and injury -- recently had a meeting with World Dementia Envoy and head of the World Dementia Council, Dr. Dennis Gillings, to discuss and plan their next steps to get closer to finding new and better pharmaceutical treatments for dementia, such as Alzheimer's Disease.
Dr. Gillings was appointed envoy earlier this year in February, shortly after last year's G8 Dementia Summit, which concluded with participating countries pledging to find a cure or disease-modifying treatment for the condition by the year 2025. He and Congressman Fattah were joined by two other noted names in dementia research and development: Jon Rouse, the Director General for Social Care at the UK Department of Health, and George Vradenburg, the co-founder of USAgainst Alzheimer's.
The representatives agreed that one of the next steps to accomplish the set of international goals is to create an internationally pooled and accessible data bank for dementia research and trials, which Dr. Gillings and Rouse both believe is a collaborative resource with "tremendous" benefits. Another proposal brought forwar